Literature DB >> 2671164

Gene transfer into hemopoietic stem cells using retroviral vectors.

J M Chang1, G R Johnson.   

Abstract

Gene transfer to hemopoietic cells offers a variety of new approaches to the experimental hematologist as well as potentially providing a means for correcting a number of genetic disorders of humans. From the experimental viewpoint, gene transfer utilizing retroviral vectors introduces new methods for analyzing hemopoietic cell lineages, and the effects of over-expression of genes affecting hemopoietic cell proliferation and differentiation. The unique properties of retroviral vectors and the optimized methods currently in use to infect hemopoietic cells are represented as a brief review of a rapidly expanding new field of experimental hematology.

Entities:  

Mesh:

Year:  1989        PMID: 2671164     DOI: 10.1002/stem.5530070502

Source DB:  PubMed          Journal:  Int J Cell Cloning        ISSN: 0737-1454


  5 in total

1.  Expression of a swine class II gene in murine bone marrow hematopoietic cells by retroviral-mediated gene transfer.

Authors:  G E Shafer; D W Emery; K Gustafsson; S Germana; W F Anderson; D H Sachs; C LeGuern
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-01       Impact factor: 11.205

2.  Retrovirus-mediated gene transfer into CD4+ and CD8+ human T cell subsets derived from tumor-infiltrating lymphocytes and peripheral blood mononuclear cells.

Authors:  S Morecki; E Karson; K Cornetta; A Kasid; P Aebersold; R M Blaese; W F Anderson; S A Rosenberg
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

3.  Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor.

Authors:  B Samal; Y Sun; G Stearns; C Xie; S Suggs; I McNiece
Journal:  Mol Cell Biol       Date:  1994-02       Impact factor: 4.272

4.  Thrombopoietin activates a STAT5-like factor in hematopoietic cells.

Authors:  C Pallard; F Gouilleux; L Bénit; L Cocault; M Souyri; D Levy; B Groner; S Gisselbrecht; I Dusanter-Fourt
Journal:  EMBO J       Date:  1995-06-15       Impact factor: 11.598

5.  Transplantable myeloproliferative disease induced in mice by an interleukin 6 retrovirus.

Authors:  R G Hawley; A Z Fong; B F Burns; T S Hawley
Journal:  J Exp Med       Date:  1992-10-01       Impact factor: 14.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.